Boston Scientific Closes $3.7B Deal for Axonics

Boston Scientific finalizes $3.7B acquisition of Axonics - MassDevice

Boston Scientific finalizes $3.7B acquisition of Axonics · A strategic move for Boston Scientific · Boston Scientific transitions Axonics ...

Boston Scientific closes $3.7B Axonics deal after lengthy review

The deal is valued at $71 per share, representing $3.7 billion in equity value and $3.3 billion in enterprise value, according to the Friday ...

Boston Scientific Closes $3.7B Deal for Axonics

Boston Scientific began the acquisition deal for Axonics in January 2024. The deal underwent significant scrutiny from the Federal Trade ...

Boston Scientific completes $3.7B purchase of California bowel ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a ...

Boston Scientific Closes Acquisition of Axonics, Inc. - Stock Titan

The $3.7 billion acquisition of Axonics marks a strategic expansion for Boston Scientific into the high-growth sacral neuromodulation market.

Boston Scientific closes acquisition of Axonics | Markets Insider

Boston Scientific (BSX) announced the close of its acquisition of Axonics (AXNX). The purchase price of $71 cash per share represents an ...

FTC asks Boston Scientific for more info on $3.7B Axonics deal

The company has pushed back its expected closing date for the acquisition due to the second request from the Federal Trade Commission.

FTC asks Boston Scientific, Axonics for more info on their $3.7B deal ...

The Federal Trade Commission (FTC) is taking a closer look at Boston Scientific's $3.7 billion proposal to acquire neuromodulation developer ...

Boston Scientific/Axonics merger to close in 2H24 as FTC seeks ...

Boston Scientific (BSX) agreed to acquire the med-tech firm for $71 per share in cash in January. The ~$3.7B deal was previously expected to be complete in the ...

Boston Scientific to acquire Axonics for $3.7B - MassDevice

Boston Scientific to acquire Axonics for $3.7B ; Open 80.77 ; Day High 82.085 ; 52 Week High 82.09 ; 52 Week Low 48.35 ...

SoniVie Names Axonics' Raymond Cohen as Chairman Following ...

Cohen is retiring from Axonics following the close of its $3.7 billion sale to Boston Scientific Corporation (NYSE: BSX). Prior to Axonics, ...

Law360 on X: "Biomedical engineering company Boston Scientific ...

Biomedical engineering company Boston Scientific ... deal's closing. https://t.co/auute7b57B. ... Boston Scientific's $3.7B Axonics Buy Under FTC ...

Boston Scientific/Axonics merger to close in 2H24 as FTC seeks ...

Boston Scientific/Axonics merger to close in 2H24 as FTC seeks more info on $3.7B deal · More on Axonics Modulation Technologies, Boston ...

Boston Scientific to acquire Axonics for $3.7B - BioWorld

for $71 per share or $3.7 billion in total in an all-cash deal. Axonics focuses on treatments for overactive bladder (OAB) and bowel dysfunction ...

Boston Scientific's $3.7B Axonics Buy Under FTC Microscope

... acquisition of medical technology company Axonics, which will result in a delay in the deal's closing.

MedTech Dive on LinkedIn: FTC asks Boston Scientific for more info ...

Boston Scientific now expects its planned $3.7 billion acquisition of Axonics, Inc. to be completed in the second half of the year, ...

FTC asks Boston Scientific, Axonics for more info on their $3.7B deal ...

The Federal Trade Commission is taking a closer look at Boston Scientific's $3.7 billion proposal to acquire the neuromodulation developer ...

Axonics to be acquired by Boston Scientific for $71 per share

Axonics (AXNX) announced that it has entered into a definitive agreement to be acquired by Boston Scientific (BSX) for $71 in cash per share ...

Boston Scientific's $3.7B Axonics Buy Under FTC Microscope ...

... $3.7 billion acquisition of medical technology company Axonics, which will result in a delay in the deal's closing.

Boston Scientific sparks 70% electrophysiology growth after ...

Boston Scientific is still working to finalize its $3.7 billion acquisition of Axonics, the maker of sacral neurostimulation implants for ...